DISCOUNT OPTIONSSCHEIN - AMGEN | Real-time Bid/Ask 15:49:15 10/05/2024 BST | ||
| 5.05 EUR / 5.18 EUR | +1.09% |
|
| Current month | +111.72% | ||
| 1 month | +97.66% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/05/24 | 5.05 | -0.20% | 0 |
| 09/05/24 | 5.06 | +17.95% | 0 |
| 08/05/24 | 4.29 | +11.14% | 0 |
| 07/05/24 | 3.86 | -21.38% | 0 |
| 06/05/24 | 4.91 | -8.74% | 0 |
Delayed Quote Börse Stuttgart
Last update May 10, 2024 at 02:23 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | Morgan Stanley |
| WKN | ME6E0V |
| ISIN | DE000ME6E0V7 |
| Date issued | 04/01/2024 |
| Strike | 370 $ |
| Maturity | 20/12/2024 (224 Days) |
| Parity | 1 : 1 |
| Emission price | 2.9 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 7.13 € |
|---|---|
| Lowest since issue | 1.94 € |
| Spread | 0.13 € |
| Spread % | 2.52% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
312.9
USD
Average target price
313.3
USD
Spread / Average Target
+0.14%
- Stock Market
- Certificates
- Certificat
